PROTAC HDAC8 Degrader-2
PROTAC HDAC8 Degrader-2 is a HDAC6/8 PROTAC degrader, with IC50 values of 0.042 μM and 0.147 μM against human HDAC8 and HDAC6, respectively, and exhibits selectivity over other class I HDAC isozymes. PROTAC HDAC8 Degrader-2 induces apoptosis (apoptosis) in leukemia cells, shows no obvious cytotoxicity to normal cells, and has favorable chemical stability. PROTAC HDAC8 Degrader-2 can be used in research related to acute myeloid leukemia.
(Pink: hHDAC6 and hHDAC8 ligand (HY-103596); Blue: Cereblon ligand (HY-103596); Black: linker).
For research use only. We do not sell to patients.
- Formula: C39H44N10O8
- Molecular Weight:780.83
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All PROTACs Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
hHDAC1 0.029 μM (IC50) |
hHDAC2 0.141 μM (IC50) |
hHDAC3 0.059 μM (IC50) |
hHDAC6 0.147 μM (IC50) |
hHDAC8 0.042 μM (IC50) |
hHDAC1 81.6 nM (DC50) |
hHDAC2 217.6 nM (DC50) |
hHDAC3 64.6 nM (DC50) |
hHDAC6 14.3 nM (DC50) |
hHDAC8 8.98 nM (DC50) |
In Vitro
PROTAC HDAC8 Degrader-2 (32a) inhibits recombinant human HDAC1, HDAC2, HDAC3, HDAC6 and HDAC8, with IC50 values of 0.029 μM, 0.141 μM, 0.059 μM, 0.147 μM and 0.042 μM, respectively[1].
PROTAC HDAC8 Degrader-2 (7.8-1000 nM; 24 h) induces dose-dependent degradation of HDAC1, HDAC2, HDAC3, HDAC8 and HDAC6 in MV-4-11 cells via the ubiquitin-proteasome system, with the highest potency against HDAC8 (DC50 = 8.98 nM) and HDAC6 (DC50 = 14.3 nM)[1].
PROTAC HDAC8 Degrader-2 (12.5-200 nM; 24 h) induces dose-dependent apoptosis in MV-4-11 leukemia cells[1].
PROTAC HDAC8 Degrader-2 (50 μM; 24 h) exhibits no significant cytotoxicity in HEK293 cells[1].
PROTAC HDAC8 Degrader-2 maintains 96% chemical stability following a 72 h incubation[1].
PROTAC HDAC8 Degrader-2 (10 μM; 5 min-6 h) exhibits favorable plasma stability in human pooled plasma, with 61% of the compound remaining after incubation at 37 °C for 6 h[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MV-4-11 leukemic cells
-
Concentration:7.8, 15.5, 31.2, 62.5, 125, 250,500 and 1000 nM (HDAC1/2/3/8 degradation);0.78, 1.56, 3.13, 6.25,12.5, 25, 50 and 100 nM (HDAC6 DC₅₀ determination 250, 500 and 1000 nM (HDAC2/HDAC1/HDAC3 degradation); 50 and 500 nM (co-treatment with inhibitors)
-
Incubation Time:24 h
-
Result:Induced 49.6% degradation of HDAC2 at 1 μM.
Nearly completely degraded HDAC3 and induced 65.5% degradation of HDAC1 at 250 nM.
Degraded HDAC8 and HDAC6 at concentrations as low as 12.5 nM, with 75.8% degradation of HDAC8 and 33.9% degradation of HDAC6 at this dose.
Yielded DC50 values of 8.98 nM for HDAC8, 81.6 nM for HDAC1, 217.6 nM for HDAC2, 64.6 nM for HDAC3, and 14.3 nM for HDAC6.
Reversed degradation when co-treated with proteasome inhibitors or neddylation inhibitor MLN4924, confirming reliance on the ubiquitin-proteasome system.
-
Cell Line:MV-4-11 leukemic cells
-
Concentration:12.5, 25, 50, 100, 150 and 200 nM
-
Incubation Time:24 h
-
Result:Induced 11.32% apoptosis at 12.5 nM.
Induced 11.67% apoptosis at 25 nM.
Induced 21.03% apoptosis at 50 nM.
Induced 59.44% apoptosis at 100 nM.
Induced 75.05% apoptosis at 150 nM.
Induced 75.16% apoptosis at 200 nM.
-
Cell Line:human HEK293 normal cells
-
Concentration:50 μM
-
Incubation Time:24 h
-
Result:Showed no significant cytotoxicity against HEK239 cells, with a cell viability of 67.4% at 50 μM.
Chemical Information
-
Molecular Weight 780.83
-
Formula C39H44N10O8
-
SMILES
O=C(C1=CN=C(N2CCN(CC3=CN(C)C4=C3C=C(OCC(NCCCCCNC5=CC=CC(C(N6C(CC7)C(NC7=O)=O)=O)=C5C6=O)=O)C=C4)CC2)N=C1)NO
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Mammalian live/dead viability and cytotoxicity staining
Live/dead viability and cytotoxicity staining assays are based on the simultaneous detection of intracellular esterase activity in metabolically active (viable) cells and membrane integrity loss in non-viable cells. In commonly used dual-staining approaches, membrane-permeant fluorogenic substrates are converted by intracellular esterases into fluorescent products in live cells, while impermeant DNA-binding dyes selectively enter cells with compromised plasma membranes and label nucleic acids in dead or dying cells, enabling discrimination between viable and non-viable populations by fluorescence microscopy or flow cytometry.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)